Volume 5.08 | Mar 3

Pulmonary Cell News 5.08 March 3, 2016
Pulmonary Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  PULCN on Twitter
 
TOP STORY
Cancer Cells’ Evasive Action Revealed
Researchers have uncovered a trick used by lung cancer cells to hide from the body’s immune system. They found links between subtle actions and reactions that allow cancerous cells to spread with little to stand in their way. [Press release from Rice University discussing online prepublication in Proceedings of the National Academy of Sciences] Press Release | Abstract
Video Protocol: Mucociliary Differentiation of Primary Bronchial Epithelial Cells
 
PUBLICATIONS (Ranked by impact factor of the journal)
Specific Regulation of PRMT1 Expression by PIAS1 and RKIP in BEAS-2B Epithelia Cells and HFL-1 Fibroblasts in Lung Inflammation
Researchers investigated the cell type specific regulatory mechanism of protein arginine methyltransferase 1 (PRMT1). Epithelial cells and fibroblasts were stimulated with IL-4 or IL-1β. [Sci Rep] Full Article

Oxidative Stress Pathways Involved in Cytotoxicity and Genotoxicity of Titanium Dioxide (TiO2) Nanoparticles on Cells Constitutive of Alveolo-Capillary Barrier In Vitro
The effect of titanium dioxide nanoparticles was examined on cell lines representative of alveolo-capillary barrier. Scientists showed that all nanoparticles-exposed cell lines displayed ROS generation. Macrophage-like THP-1 and HPMEC-ST1.6R microvascular cells were sensitive to endogenous redox changes and underwent apoptosis, but not alveolar epithelial A549 cells. [Toxicol In Vitro] Abstract

Pleurotus nebrodensis Polysaccharide (PN50G) Evokes A549 Cell Apoptosis by the ROS/AMPK/PI3K/AKT/mTOR Pathway to Suppress Tumor Growth
Since the strong antineoplastic potential against A549 cells of PN50G in vitro has been proven previously, the definitive mechanism of PN50G-induced apoptosis in A549 cells in vivo was investigated. [Food Funct] Abstract

Involvement of B-Cell CLL/Lymphoma 2 Promoter Methylation in Cigarette Smoke Extract-Induced Emphysema
Researchers determined whether the anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) play a role in the cigarette smoke extract-induced emphysema. Furthermore, given the involvement of epigenetics in chronic obstructive pulmonary disease, they hypothesized that the deregulation of Bcl-2 might be caused by gene methylation. [Exp Biol Med] Abstract

LUNG CANCER

Human Lung Adenocarcinoma Cell Cultures Derived from Malignant Pleural Effusions as Model System to Predict Patients Chemosensitivity
Using malignant pleural effusions from non-small cell lung cancer patients, scientists established a collection of patient-derived adenocarcinoma cultures which were characterized for their sensitivity to chemotherapeutic drugs used in the clinical practice. [J Transl Med] Full Article

More Expression of BDNF Associates with Lung Squamous Cell Carcinoma and Is Critical to the Proliferation and Invasion of Lung Cancer Cells
The authors explored the function of brain-derived neurotrophic factor (BDNF) in lung squamous cell carcinoma and adenocarcinoma. BDNF expression was also evaluated in human bronchial epithelial cells and four lung cancer cell lines using western blot. [BMC Cancer] Full Article

Cyclopamine Tartrate, an Inhibitor of Hedgehog Signaling, Strongly Interferes with Mitochondrial Function and Suppresses Aerobic Respiration in Lung Cancer Cells
To find novel strategies for combating lung cancer, investigators characterized the effect of cyclopamine tartrate, an improved analogue of cyclopamine, on lung cancer cells and its mechanism of action. [BMC Cancer] Full Article

BMS-754807 Is Cytotoxic to Non-Small Cell Lung Cancer Cells and Enhances the Effects of Platinum Chemotherapeutics in the Human Lung Cancer Cell Line A549
The dual type I insulin-like growth factor receptor/insulin receptor inhibitor, BMS-754807, was evaluated alone and in combination with platinum-based chemotherapeutics in two human non-small cell lung cancer cell lines. [BMC Res Notes] Full Article

Watch Now: Webinar on Gastrointestinal Organoids by Dr. Meritxell Huch
 
REVIEWS
Emerging Roles of Nrf2 Signal in Non-Small Cell Lung Cancer
In non-small cell lung cancer patients, deregulated nuclear factor erythroid 2-like factor 2 (Nrf2) signal is recognized as a common feature at both DNA and protein level. Emerging associations between Nrf2 and other pathways have been elucidated. [J Hematol Oncol] Abstract

Visit our reviews page to see a complete list of reviews in the pulmonary cell research field.
 
INDUSTRY NEWS
Genentech Provides Update on Two Identical Phase III Studies of Lebrikizumab in People with Severe Asthma
Genentech announced top-line results from two Phase III studies. The LAVOLTA I-II studies were identical, double-blind, randomized, multicenter, placebo-controlled studies that evaluated the efficacy and safety of lebrikizumab in people with severe asthma. [Genentech, Inc.] Press Release

European Committee for Medicinal Products for Human Use Recommends Approval of Giotrif® (Afatinib) for Advanced Squamous Cell Cancer of the Lung
Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion for the approval of Giotrif® for the treatment of patients with advanced squamous cell carcinoma of the lung whose disease has progressed on or after treatment with platinum-based chemotherapy. [Boehringer Ingelheim GmbH] Press Release

Bristol-Myers Squibb Receives Two Positive CHMP Opinions for Opdivo® (Nivolumab) for Patients with Previously Treated Advanced Non-Squamous Non-Small Cell Lung Cancer and Renal Cell Carcinoma
Bristol-Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Opdivo for two new indications – adults with locally advanced or metastatic non-small cell lung cancer after prior chemotherapy, and adults with advanced renal cell carcinoma after prior therapy. [Bristol-Myers Squibb Company] Press Release

Bonnie J. Addario Lung Cancer Foundation and International Association for the Study of Lung Cancer Announce Joint Award
The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the International Association for the Study of Lung Cancer (IASLC) announced the first ever $300,000 ALCF-IASLC Joint International Fellowship Award for The Early Detection of Lung Cancer to Robin Mjelle, PhD, researcher at the Department of Cancer Research and Molecular Medicine at the Norwegian University of Science and Technology. [The Bonnie J. Addario Lung Cancer Foundation] Press Release

From our sponsor: Learn how to form and isolate neural rosettes more efficiently. Watch the video.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Asia Pacific Lung Cancer Conference (APLCC) 2016
May 13-15, 2016
Chiang Mai, Thailand

Visit our events page to see a complete list of events in the pulmonary cell community.
 
JOB OPPORTUNITIES
NEW Faculty Positions – Cancer Research (Texas Tech University Health Sciences Center)

Postdoctoral Fellow – Lung Cancer (The University of Texas MD Anderson Cancer Center)

Associate or Full Professor – Cardiothoracic Surgery (University of California San Diego)

Postdoctoral Research Fellow – Lung Cancer (Cornell University)

Postdoctoral Fellow – Lung Cancer Research (German Cancer Research Center)

Project Scientist – Pulmonary Fibrosis (Cedars Sinai Medical Center)

Postdoctoral Fellow – Bioinformatics RNA Biology & Cancer (German Cancer Research Center)

Postdoctoral Fellow/Research Associate – Cancer Therapy (Memorial Sloan Kettering Cancer Center)

Director Clinical Research – Medical Oncology (Fred Hutchinson Cancer Research Center)

Postdoctoral Researcher – Immunology (Research Centre for Respiratory Diseases)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Pulmonary Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Pulmonary Cell News: Archives | Events | Contact Us